SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,538,458 | -0.9% | 109,795 | +12.4% | 0.01% | 0.0% |
| Q2 2023 | $2,561,405 | -9.4% | 97,689 | -11.0% | 0.01% | -16.7% |
| Q1 2023 | $2,825,942 | +25.9% | 109,788 | +27.2% | 0.01% | +20.0% |
| Q4 2022 | $2,245,052 | -23.5% | 86,315 | -16.2% | 0.01% | -16.7% |
| Q3 2022 | $2,936,000 | +92.0% | 102,981 | +65.7% | 0.01% | +100.0% |
| Q2 2022 | $1,529,000 | -44.8% | 62,150 | +26.7% | 0.00% | -40.0% |
| Q1 2022 | $2,768,000 | +7.5% | 49,050 | +18.0% | 0.01% | +25.0% |
| Q4 2021 | $2,575,000 | +29.7% | 41,572 | +32.8% | 0.00% | +33.3% |
| Q3 2021 | $1,985,000 | -7.0% | 31,309 | +20.8% | 0.00% | -25.0% |
| Q2 2021 | $2,135,000 | +2746.7% | 25,920 | +1340.0% | 0.00% | – |
| Q2 2020 | $75,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |